Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1861 4
1862 1
1873 1
1929 2
1946 5
1947 1
1948 2
1950 1
1951 4
1952 2
1953 3
1954 1
1955 1
1956 5
1958 2
1959 3
1960 4
1961 8
1962 9
1963 7
1964 4
1965 6
1966 12
1967 5
1968 7
1969 18
1970 9
1971 11
1972 6
1973 19
1974 8
1975 5
1976 11
1977 17
1978 11
1979 17
1980 18
1981 14
1982 11
1983 15
1984 15
1985 16
1986 6
1987 9
1988 13
1989 13
1990 14
1991 12
1992 6
1993 7
1994 14
1995 15
1996 10
1997 14
1998 21
1999 11
2000 15
2001 21
2002 11
2003 11
2004 7
2005 7
2006 3
2007 15
2008 10
2009 21
2010 12
2011 19
2012 14
2013 12
2014 21
2015 24
2016 24
2017 29
2018 39
2019 33
2020 25
2021 41
2022 47
2023 43
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

950 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Lane HC, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. Singh K, et al. J Infect Dis. 2024 Apr 24:jiae198. doi: 10.1093/infdis/jiae198. Online ahead of print. J Infect Dis. 2024. PMID: 38657001
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
Sherman A, Tuan J, Cantos VD, Adeyiga O, Mahoney S, Ortega-Villa AM, Tillman A, Whitaker J, Woodward Davis AS, Leav B, Hirsch I, Sadoff J, Dunkle LM, Gilbert PB, Janes HE, Kublin JG, Goepfert PA, Kotloff K, Rouphael N, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, Neuzil KM, Corey L, Grinsztejn B, Gray G, Nason M, Baden LR, Gay CL. Sherman A, et al. Among authors: whitaker j. Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093/cid/ciae192. Online ahead of print. Clin Infect Dis. 2024. PMID: 38598658
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adults.
Rostad CA, Atmar RL, Walter EB, Frey S, Meier JL, Sherman AC, Lai L, Tsong R, Kao CM, Raabe V, El Sahly HM, Keitel WA, Whitaker JA, Smith MJ, Schmader KE, Swamy GK, Abate G, Winokur P, Buchanan W, Cross K, Wegel A, Xu Y, Yildirim I, Kamidani S, Rouphael N, Roberts PC, Mulligan MJ, Anderson EJ. Rostad CA, et al. Among authors: whitaker ja. Clin Infect Dis. 2024 Mar 27:ciae173. doi: 10.1093/cid/ciae173. Online ahead of print. Clin Infect Dis. 2024. PMID: 38537255
Skin Cancer Risk Is Increased by Somatic Mutations Detected Noninvasively in Healthy-Appearing Sun-Exposed Skin.
Kaur K, Ai R, Perry AG, Riley B, Roberts EL, Montano EN, Han J, Roacho J, Lopez BG, Skelsey MK, Childs MV, Childs JN, Dobak J, Ibarra C, Jansen B, Clarke LE, Stone S, Whitaker JW. Kaur K, et al. Among authors: whitaker jw. J Invest Dermatol. 2024 Mar 19:S0022-202X(24)00176-3. doi: 10.1016/j.jid.2024.02.017. Online ahead of print. J Invest Dermatol. 2024. PMID: 38513819 Free article.
Perennial biomass cropping and use: Shaping the policy ecosystem in European countries.
Clifton-Brown J, Hastings A, von Cossel M, Murphy-Bokern D, McCalmont J, Whitaker J, Alexopoulou E, Amaducci S, Andronic L, Ashman C, Awty-Carroll D, Bhatia R, Breuer L, Cosentino S, Cracroft-Eley W, Donnison I, Elbersen B, Ferrarini A, Ford J, Greef J, Ingram J, Lewandowski I, Magenau E, Mos M, Petrick M, Pogrzeba M, Robson P, Rowe RL, Sandu A, Schwarz KU, Scordia D, Scurlock J, Shepherd A, Thornton J, Trindade LM, Vetter S, Wagner M, Wu PC, Yamada T, Kiesel A. Clifton-Brown J, et al. Among authors: whitaker j. Glob Change Biol Bioenergy. 2023 May;15(5):538-558. doi: 10.1111/gcbb.13038. Epub 2023 Mar 13. Glob Change Biol Bioenergy. 2023. PMID: 38505831 Free PMC article. Review.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
950 results